A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
Status:
Completed
Trial end date:
2021-01-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about how tirzepatide affects stomach emptying in
overweight/very overweight participants. Participants include those without diabetes and
those with type 2 diabetes.
The study will last about 13 weeks for each participant, including screening.